Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BESPEC
- Development stage
- Preclinical
- Lead developer
- WASSC Technologies
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
BESPEC is a preclinical-stage therapeutic candidate being developed by WASSC Technologies. It is characterized as a multi-specific therapy platform that integrates antibody-drug conjugate (ADC) technology. According to company pipeline data, the program is in the research phase with approximately 45% progress. While the specific molecular targets and intended clinical indications have not been publicly disclosed, the BESPEC platform is designed to utilize multi-specific binding properties to potentially improve targeting precision and therapeutic outcomes compared to monospecific approaches.
- Other names
- Thérapie multi-spécifiqueMulti-specific therapy
Beyond the preview
Go deeper on BESPEC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BESPEC.